Le Lézard
Classified in: Covid-19 virus

The Worldwide Cardiac Arrest Treatment Industry is Expected to Reach $27+ Billion by 2026 - ResearchAndMarkets.com


The "Global Cardiac Arrest Treatment Market (2021-2026) by Treatment, Distribution Channel and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Cardiac Arrest Treatment Market is estimated to be USD 17.63 Bn in 2021 and is expected to reach USD 27.39 Bn by 2026, growing at a CAGR of 9.21%.

The major factor raising the global cardiac arrest treatment market is an increase in cardiovascular disorders (CVDs). The increasingly sedentary lifestyle, high alcohol & tobacco consumption, and rising geriatric population are leading to the increase in CVDs. Furthermore, increasing awareness of cardiac resynchronization therapy devices among the population is escalating the market growth. However, frequent product calls and the high cost of Treatment are anticipated to hinder the market during the forecast period.

Huge investments in research and development associated with cardiac arrest treatment are expected to foster new opportunities for the market during the forecast period.

The Global Cardiac Arrest Treatment Market is segmented based on Treatment, Distribution Channel and Geography.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

Market Dynamics

Drivers

Restraints

Opportunities

Challenges

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/j1yxb5


These press releases may also interest you

at 03:00
Sedentary lifestyles, missed medical appointments and the broader health impact of the COVID-19 pandemic may take the UK years to recover from. That's according to the new Bupa Wellbeing Index, a landmark survey conducted amongst 8,000 UK adults that...

at 02:30
Cognata, Ltd., announced today the integration of Cognata's simulation authoring software into Hancom's advanced portfolio, to further accelerate AV and ADAS simulation adoption into the progressive Korean market. Cognata's extensive simulation...

at 02:25
Faron Pharmaceuticals Ltd. ("Faron" or "Company") Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies Phase 1 dose escalation study...

at 02:10
According to the report "Digital Educational Publishing Market in Europe by End-user and Geography - Forecast and Analysis 2021-2025", the market witnessed a YOY growth of 14.44% in 2021 at a CAGR of 15.58% during the forecast period. The report is...

at 02:00
ONE ZERO Digital Bank is proud to announce it has chosen AU10TIX to power its customer verification system and KYC (Know Your Customer) platform. The Bank of Israel, Israel's central bank, gave ONE ZERO Digital Bank its stamp of approval to use...

at 01:00
Sohu.com Limited ("Sohu" or the "Company"), China's leading online media, video, and game business group, today reported unaudited financial results for the first quarter ended March 31, 2022. First Quarter Highlights Total revenues were US$193...



News published on 21 january 2022 at 08:30 and distributed by: